Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo, Aobaku, Sendai, 980-8574, Japan.
Division of Gastroenterology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aobaku, Sendai, Miyagi, 981-8558, Japan.
J Gastroenterol. 2018 Aug;53(8):978-988. doi: 10.1007/s00535-018-1435-5. Epub 2018 Jan 27.
It is poorly understood how an imbalance of plasma-free amino acids (PFAAs) occurs and how the imbalance shows an association with the serum albumin (sAlb) level during the progression of chronic liver disease (CLDs). The aim of this study is to elucidate the profiles of PFAAs and the relationship between sAlb and PFAAs in recent patients with CLDs during the progression.
We retrospectively evaluated the 1569 data of PFAAs data obtained from 908 patients with various CLDs (CHC, CHB. alcoholic, NAFLD/NASH, PBC, AIH, PSC, and cryptogenic). In total, 1140 data of PFAAs could be analyzed in patients with CLDs dependent of their Child-Pugh (CP) score.
Various imbalances in PFAAs were observed in each CLDs during the progression. Univariate and multivariate analysis revealed that among 24 PFAAs, the level of plasma-branched chain amino acids (pBCAAs) was significantly associated with the CP score, especially the sAlb score, in patients with chronic hepatitis C virus (CHC), NAFLD/NASH and PBC. The correlation coefficient values between sAlb and pBCAAs-to-Tyrosine ratio (BTR) in these patients were 0.53, 0.53 and 0.79, respectively. Interestingly, although the pBCAAs in NAFLD/NASH patients varied even when the sAlb was within the normal range, the pBCAAs tended to be low when the sAlb was below the normal range.
Although a decrease in the level of pBCAAs was observed during the progression regardless of the CLD etiology, the level of total pBCAAs was independently associated with the sAlb level in the PFAAs of CHC, PBC and NAFLD/NASH. The correlation between sAlb and BTR showed the highest value in PBC patients among the patients with CLDs. A decrease in pBCAAs often occurred in NASH even when the sAlb level was kept in the normal range.
目前对于慢性肝病(CLD)进展过程中血浆游离氨基酸(PFAAs)失衡的发生机制以及这种失衡与血清白蛋白(sAlb)水平之间的关联尚不清楚。本研究旨在阐明 CLD 患者近期 PFAAs 谱的特征,以及 sAlb 与 PFAAs 之间的关系。
我们回顾性评估了 908 例各种 CLD 患者(CHC、CHB、酒精性、NAFLD/NASH、PBC、AIH、PSC 和隐源性)的 1569 个 PFAAs 数据。共有 1140 例 CLD 患者可根据 Child-Pugh(CP)评分进行 PFAAs 分析。
在 CLD 进展过程中,每种 CLD 均观察到各种 PFAAs 失衡。单因素和多因素分析显示,在 24 种 PFAAs 中,血浆支链氨基酸(pBCAAs)水平与 CP 评分,尤其是慢性丙型肝炎病毒(CHC)、NAFLD/NASH 和 PBC 患者的 sAlb 评分显著相关。这些患者的 sAlb 与 pBCAAs-酪氨酸比(BTR)之间的相关系数值分别为 0.53、0.53 和 0.79。有趣的是,尽管 NAFLD/NASH 患者的 pBCAAs 即使在 sAlb 处于正常范围内也会发生变化,但当 sAlb 低于正常范围时,pBCAAs 往往会降低。
尽管无论 CLD 病因如何,pBCAAs 水平在进展过程中均下降,但在 CHC、PBC 和 NAFLD/NASH 的 PFAAs 中,总 pBCAAs 水平与 sAlb 水平独立相关。sAlb 与 BTR 之间的相关性在 CLD 患者中以 PBC 患者最高。即使 sAlb 水平保持在正常范围内,NASH 患者也经常出现 pBCAAs 下降。